Uridine triacetate 10000 MG Oral Granules [Vistogard] — RxCUI 1739800
RxNorm drug concept · Semantic branded drug
RxCUI 1739800
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1739800
Official nameUridine triacetate 10000 MG Oral Granules [Vistogard]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVistogard 10 GM Oral Granules; Vistogard 10,000 MG Oral Granules
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Uridine Triacetate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Vistogard is an emergency antidote for people who have received too much of certain chemotherapy drugs — fluorouracil or capecitabine — or who develop serious, early reactions to t...
- What exactly is Vistogard and why would I need it urgently?
- Xuriden and Vistogard are actually two different products, even though both contain uridine triacetate. Xuriden is a daily medication for people with hereditary orotic aciduria, a...
- What is Xuriden used for, and is it the same as Vistogard?
🕸️ Concept Web — How Uridine triacetate 10000 MG Oral Granules [Visto... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Uridine triacetate 10000 MG Oral Granules [Vistogard]
RxCUI 1739800 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Uridine triacetate
1665222IN
-
Uridine triacetate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vistogard
1739795BN
-
Vistogard
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Uridine triacetate Oral Granules
1665466SCDF -
Uridine triacetate Granule Product
1665464SCDG -
Uridine triacetate Oral Product
1665465SCDG -
Uridine triacetate Oral Granules [Vistogard]
1739797SBDF -
Vistogard Granule Product
1739798SBDG -
Vistogard Oral Product
1739799SBDG -
Oral Granules
317690DF -
Granule Product
1294708DFG - +1 more in this family
-
Uridine triacetate Oral Granules
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Uridine triacetate 10000 MG Oral Granules
1739794SCD -
Uridine triacetate 10000 MG
1739793SCDC -
Uridine triacetate 10000 MG [Vistogard]
1739796SBDC
-
Uridine triacetate 10000 MG Oral Granules
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Uridine triacetate 10000 MG Oral Granules
SCD · 1739794 -
Uridine triacetate 10000 MG
SCDC · 1739793 -
Uridine triacetate Oral Granules
SCDF · 1665466 -
Uridine triacetate Granule Product
SCDG · 1665464 -
Uridine triacetate Oral Product
SCDG · 1665465
Brand-Name Concepts
-
Uridine triacetate 10000 MG [Vistogard]
SBDC · 1739796 -
Uridine triacetate Oral Granules [Vistogard]
SBDF · 1739797 -
Vistogard Granule Product
SBDG · 1739798 -
Vistogard Oral Product
SBDG · 1739799 -
Vistogard
BN · 1739795
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 1739800 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50633-0220-04 | 4 PACKET in 1 CARTON (50633-220-04) / 10 g in 1 PACKET (506... | VISTOGARD | BTG International Inc | 2024-07-31 |
| 50633-0220-20 | 20 PACKET in 1 CARTON (50633-220-20) / 10 g in 1 PACKET (50... | VISTOGARD | BTG International Inc | 2024-07-31 |
Observed labelers:
BTG International Inc (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.